Literature DB >> 2094817

D2 dopamine receptor gene expression by cholinergic neurons in the rat striatum.

C Le Moine1, F Tison, B Bloch.   

Abstract

In situ hybridization with D2 receptor probe and immunohistochemistry with choline acetyltransferase (ChAT) antibody performed on adjacent sections demonstrate dopamine D2 receptor gene expression in cholinergic neurons of the rat caudate-putamen and nucleus accumbens. Eighty per cent of cholinergic neurons in the striatum contain detectable D2 receptor mRNA. The other neurons without detectable D2 mRNA do not display specific localization or aspect in the caudate-putamen and nucleus accumbens as compared to the other cholinergic neurons. The absence of detectable D2 mRNA in certain cholinergic neurons can be due to the limited sensitivity of the procedure that would not detect low mRNA levels, or alternatively can reflect the existence of two cholinergic cell populations in the striatum, one of which would not express the D2 receptor gene. The other forebrain cholinergic neurons do not contain D2 mRNA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2094817     DOI: 10.1016/0304-3940(90)90671-u

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  24 in total

1.  High-Frequency Activation of Nucleus Accumbens D1-MSNs Drives Excitatory Potentiation on D2-MSNs.

Authors:  T Chase Francis; Hideaki Yano; Tyler G Demarest; Hui Shen; Antonello Bonci
Journal:  Neuron       Date:  2019-06-17       Impact factor: 17.173

2.  Antipsychotic-induced catalepsy is attenuated in mice lacking the M4 muscarinic acetylcholine receptor.

Authors:  Anders Fink-Jensen; Lene S Schmidt; Ditte Dencker; Christina Schülein; Jürgen Wess; Gitta Wörtwein; David P D Woldbye
Journal:  Eur J Pharmacol       Date:  2011-01-24       Impact factor: 4.432

3.  Dopamine-adenosine interactions in the striatum and the globus pallidus: inhibition of striatopallidal neurons through either D2 or A2A receptors enhances D1 receptor-mediated effects on c-fos expression.

Authors:  C Le Moine; P Svenningsson; B B Fredholm; B Bloch
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

Review 4.  Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions.

Authors:  Kalynda K Gonzales; Yoland Smith
Journal:  Ann N Y Acad Sci       Date:  2015-04-15       Impact factor: 5.691

Review 5.  Disentangling the diverse roles of dopamine D2 receptors in striatal function and behavior.

Authors:  Eduardo F Gallo
Journal:  Neurochem Int       Date:  2019-02-01       Impact factor: 3.921

6.  Alterations in striatal acetylcholine overflow by cocaine, morphine, and MK-801: relationship to locomotor output.

Authors:  A Zocchi; A Pert
Journal:  Psychopharmacology (Berl)       Date:  1994-07       Impact factor: 4.530

7.  Amelioration of binge eating by nucleus accumbens shell deep brain stimulation in mice involves D2 receptor modulation.

Authors:  Casey H Halpern; Anand Tekriwal; Jessica Santollo; Jeffrey G Keating; John A Wolf; Derek Daniels; Tracy L Bale
Journal:  J Neurosci       Date:  2013-04-24       Impact factor: 6.167

8.  Impaired striatal D2 receptor function leads to enhanced GABA transmission in a mouse model of DYT1 dystonia.

Authors:  Giuseppe Sciamanna; Paola Bonsi; Annalisa Tassone; Dario Cuomo; Anne Tscherter; Maria Teresa Viscomi; Giuseppina Martella; Nutan Sharma; Giorgio Bernardi; David G Standaert; Antonio Pisani
Journal:  Neurobiol Dis       Date:  2009-01-13       Impact factor: 5.996

9.  Dopamine and cyclic-AMP regulated phosphoprotein-32-dependent modulation of prefrontal cortical input and intercellular coupling in mouse accumbens spiny and aspiny neurons.

Authors:  S-P Onn; M Lin; J-J Liu; A A Grace
Journal:  Neuroscience       Date:  2007-11-28       Impact factor: 3.590

10.  Muscarinic antagonists attenuate the increase in accumbens and striatum dopamine metabolism produced by clozapine but not by haloperidol.

Authors:  R Rivest; C A Marsden
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.